In conclusion, our data suggested that afatinib stimulated REDD1-TSC1 signaling via ROS accumulation, which in turn inhibited mTORC1 to promote autophagy in HNSCC cells. This evidence concerns the gene TSC1 and head and neck squamous cell carcinoma.